Bausch Health director receives equity grant

Bausch Health Companies Inc. director Sandra Leung received an equity compensation grant rather than cash for her board service.

Rhea-AI Filing Summary

Bausch Health Companies Inc. director Sandra Leung received an equity compensation grant rather than cash for her board service. She acquired 6,845 common shares on June 30, 2026, valued at $4.93 per share, in the form of Restricted Share Units for the quarter ending June 30, 2026.

Each unit represents a contingent right to receive one common share, and following this grant she directly holds a reported total of 97,070 common shares. This is a routine, compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 6,845 shares

Grant/Award 1 txn

Insider LEUNG SANDRA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	6,845	$4.93	$34K

Holdings After Transaction: Common Shares, No Par Value — 97,070 shares (Direct)

Footnotes (1)

1. F1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

Key Figures

RSU grant size: 6,845 units Indicated grant price: $4.93 per share Post-grant holdings: 97,070 shares +3 more

6 metrics

RSU grant size 6,845 units Restricted Share Units granted June 30, 2026

Indicated grant price $4.93 per share Value per unit for the June 30, 2026 award

Post-grant holdings 97,070 shares Total common shares directly held after the grant

Buy transactions 0 No open-market purchases reported in this Form 4

Sell transactions 0 No open-market sales reported in this Form 4

Acquire transactions 1 Single grant/award acquisition reported

Key Terms

Restricted Share Units, in lieu of cash compensation, contingent right, Grant, award, or other acquisition, +1 more

5 terms

Restricted Share Units financial

"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

in lieu of cash compensation financial

"Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service"

contingent right financial

"each representing a contingent right to receive one common share, no par value, of the Issuer"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Shares, No Par Value financial

"security_title: Common Shares, No Par Value"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bausch Health (BHC) report for Sandra Leung?

Bausch Health reported that director Sandra Leung received a grant of 6,845 Restricted Share Units on June 30, 2026. These units were issued as equity compensation for her board service instead of cash for that quarter.

Was the Bausch Health (BHC) insider transaction a purchase or a grant?

The transaction was a grant/award acquisition, not an open-market purchase. Director Sandra Leung received 6,845 Restricted Share Units as compensation, each representing a contingent right to receive one Bausch Health common share.

What price and total holdings are reported for Sandra Leung’s Bausch Health (BHC) grant?

The grant reflects an indicated value of $4.93 per share for 6,845 units. After this equity award, Sandra Leung is reported to directly hold 97,070 Bausch Health common shares, according to the Form 4 filing data.

Why did Bausch Health (BHC) issue Restricted Share Units to Sandra Leung?

Bausch Health issued the Restricted Share Units in lieu of cash compensation for Sandra Leung’s service on the board. The award covers the quarter ending June 30, 2026, aligning director pay with the company’s equity performance.

Do the granted units immediately become Bausch Health (BHC) common shares?

No, the units represent a contingent right to receive one common share each. They are classified as Restricted Share Units, which typically convert into common shares after meeting specified conditions stated in the company’s compensation arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEUNG SANDRA

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	06/30/2026		A		6,845(1)	A	$4.93	97,070	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)